Genetic Information Amendments

The deadline for facilities to submit their first compliance sworn statement was extended from December 31, 2027, to December 31, 2028.

The date fines for using prohibited genetic sequencers or storing data in foreign adversaries became enforceable was delayed from May 1, 2027, to May 1, 2028.

A new exemption was created for genetic sequencing data gathered as part of a clinical trial, provided the subjects are outside the U.S. or the study is permitted under specific federal regulations.

Added a new requirement for facilities to submit a sworn compliance statement every 10 years, alongside the existing annual requirement.

Added Senate Sponsor Keven J. Stratton to the bill header.

Added a new provision exempting entities subject to the Genetic Information Privacy Act from the annual compliance certification and penalty requirements of this bill.

Updated the timestamp of the bill's revision from January 17 to January 22.

The bill's effective date was changed from January 1, 2028, to May 5, 2027.

The deadline for facilities to submit annual compliance statements was moved from December 31, 2028, to December 31, 2027.

The date fines for using prohibited genetic sequencers or storing data in foreign adversaries became enforceable was moved from May 1, 2028, to May 1, 2027.

Added precise legal definitions for critical terms including 'foreign adversary,' 'genetic sequencer,' 'open data,' and 'operational and research software' to ensure consistent enforcement.

Established a mandatory requirement for facilities to submit sworn compliance statements to the attorney general every 10 years, with the first due by December 31, 2028.

Created specific penalties of $10,000 per violation for using prohibited equipment or storing data in foreign adversary territories, enforceable starting May 1, 2028.

Included a whistleblower protection clause preventing employers from taking adverse actions against employees who notify the attorney general of potential violations.

Set the official effective date of the bill to January 1, 2028, providing a two-year grace period for facilities to comply with new restrictions.

Converted the text from a fragmented 'Amended Excerpts' draft into a complete, formally enacted statute with a clear long title and section numbering.

Clarified the exemption for clinical trial data by adding the condition that storage, transfer, or remote access must be permitted under 28 C.F.R. Part 202.

Corrected formatting and line breaks in the compliance reporting deadline section to improve readability.

The effective date for fines and enforcement was moved from May 1, 2027, to May 1, 2028.

The deadline for the initial compliance certification was moved from December 31, 2027, to December 31, 2028.

Facilities must now submit a sworn compliance statement to the attorney general and the department every 10 years, in addition to the initial statement.

Genetic sequencing data gathered as part of a clinical trial is exempt from storage restrictions if the subjects are outside the US or the trial complies with specific federal regulations.

The Senate Sponsor name was changed from 'LONG TITLE' to 'Keven J. Stratton'.